News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Deals
CyGenics Ltd Expands Into Europe With Plans To Acquire PharmaCell BV Stake
April 11, 2006
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
CyGenics Ltd. announced its plans to establish a sound base in the European market to take advantage of exciting business opportunities in those markets. As a first step, CyGenics plans to acqui re a significant stake in Dutch-based PharmaCell BV.
Twitter
LinkedIn
Facebook
Email
Print
Mergers & acquisitions
Real estate
Australia
MORE ON THIS TOPIC
Job Trends
Bonus: Q2 2026 Job Market Update
July 14, 2026
·
1 min read
·
Angela Gabriel
Deals
Spero bets up to $1.1B for Innovent’s autoimmune antibody
July 14, 2026
·
2 min read
·
Tristan Manalac
Lung cancer
AstraZeneca takes another China trip, picking Dizal’s lung cancer drug for up to $1.5B
July 14, 2026
·
2 min read
·
Tristan Manalac
Antibody-drug conjugates
GSK and Hansoh’s ADC clinches late-stage win, teeing up regulatory submission in China
July 10, 2026
·
1 min read
·
Gabrielle Masson
